HRS 22: Complications Among S-ICD Vs TV-ICD Recipients: The ATLAS Trial

Published: 05 May 2022

  • Views:

    Views Icon 244
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

In this short interview, Dr Jeff Healey (McMaster University, Hamilton, CA) talks about the key data from the ATLAS (Avoid Transvenous Leads in Appropriate Subjects) trial (NCT02881255).The aim of the study was to compare standard, single chamber transvenous ICD (TV-ICD) to sub-cutaneous ICD (S-ICD) (Boston Scientific EMBLEM) in occurrence of perioperative and long term device related complications and failed appropriate clinical shocks and arrhythmic death.

Discussion Points

  1. Trial Backgound
  2. Study Design & Eligibility Criteria
  3. Key Findings
  4. When to Select S-ICD Over TV-ICD
  5. Implications for Practice & for Guidelines
  6. Next Steps

Recorded on-site at Heart Rhythm 2022, San Francisco. 

Videography:Dan Brent